Ashwasena (अश्वसेन) retweeted
New perspectives on thick ascending limb function and cell types - Kidney International kidney-international.org/art…
3
6
569
Ashwasena (अश्वसेन) retweeted
How can nephrologists better integrate cardiovascular, kidney, and metabolic care? New ASN guidance offers practical recommendations for CKM risk assessment, treatment, and multidisciplinary care for people living with kidney diseases. kidney.pub/KN1809-04 #ASNKidneyNews
8
18
2,543
Once there was a village in Nepal, where homes held laughter and dreams. Then the floods came, sweeping it all away. Tears flowed with the rivers, but courage rose higher than the waves. From ruins, hope will rebuild. 🌊💔 #NepalFloods #Resilience #Nepal
1
3
310
Ashwasena (अश्वसेन) retweeted
C3G and Ig-MPGN—treatment standard
🔓doi.org/10.1093/ndt/gfad182
41
85
6,492
Crying as I write this 😢… In the floods of Nepal, your messages reached me like a hug across the storm. Thank you, my friends, for holding us in your hearts. 💔🙏 #NepalFloods #Gratitude
#Nepal
3
17
1,299
The infinite loop: “More studies are needed… which will also conclude that more studies are needed.”😊
1
489
Ashwasena (अश्वसेन) retweeted
INSTEAD OF WATCHING AN HOUR OF NETFLIX TONIGHT.
This 1 hour Stanford lecture by Joel Peterson will teach you more about negotiation and getting what you want than most people learn in years.
Bookmark it and give it an hour, no matter what.
11
170
680
68,149
Ashwasena (अश्वसेन) retweeted
Now open access in @NDTsocial @SaynaNorouzi
Risk factor obesity: Treatment Standard
🧐Novel developments: pathophysiology, diagnosis, outcome prediction, and management of obesity as a RF for CKD and its progression to KF
▶️academic.oup.com/ndt/article…
1
23
42
2,613
Ashwasena (अश्वसेन) retweeted
Now online in @NDTsocial
Proteinuria remission and long-term kidney outcome in children with IgAN
🧐55% of children achieve a complete and sustained remission of IgAN
▶️ academic.oup.com/ndt/article…
1
10
30
2,053
Ashwasena (अश्वसेन) retweeted
Hypogammaglobulinemia and B cell repopulation after rituximab in childhood nephrotic syndrome
rdcu.be/ftpWJ
@Ped_Neph @ASPNeph
6
9
795
Ashwasena (अश्वसेन) retweeted
Study conclusion: Tacrolimus is non inferior to steroid for adult MCD at 8 weeks of treatment with no difference of side effects.
Implications: Start Tacrolimus; why to wait till steroid response and switch to tacrolimus if steroid resistant n steroid side effects
#nephjc
Minimal Role for Steroids in Minimal Change Disease? nephjc.com/news/mintac
2
1
12
Ashwasena (अश्वसेन) retweeted
Now online in @NDTsocial
Impact of immunosuppressive therapy in rapidly progressive secondary IgAN
🧐Treatment escalation was not associated with improved renal or patient survival
▶️academic.oup.com/ndt/article…
1
15
24
4,585
Ashwasena (अश्वसेन) retweeted
Genetic insights into congenital and infantile nephrotic syndrome: predicting severity and informing care @ASPNeph @Ped_Neph
link.springer.com/article/10…
8
12
2,220
Is it permissible for an author to share a copy of their article with another researcher for academic purposes if the article is published in a journal that requires payment for access?
1
2
538
Ashwasena (अश्वसेन) retweeted
I'm 59.
Here are 18 uncomfortable truths I wish I knew earlier:
5
124
684
620,945
Ashwasena (अश्वसेन) retweeted
Just released the Impact Factors of some #kidney journals. @ERAkidney @ISNkidneycare @asnpublications @NatRevNeph
8
26
68
8,842
Ashwasena (अश्वसेन) retweeted
📹Watch Dr Daniel Kraus present the NDT publication:
Bleeding risk after kidney biopsy with platelet inhibition
👇👇👇
oup.cloud.panopto.eu/Panopto…
6
9
916
Ashwasena (अश्वसेन) retweeted
Now open access in @NDTsocial
Bleeding risk after kidney biopsy with platelet inhibition
🧐Platelet inhibition is not associated with increased risk of serious complications after kidney biopsy.
▶️academic.oup.com/ndt/article…
2
27
65
4,426